Results reveal whether you're likely to respond strongly to tirzepatide's GIPR activation or whether semaglutide monotherapy aligns better with your genetic profile, helping you avoid unnecessary dose escalations and supporting sustainable weight loss from the start
Nobody questions whether a person with high blood pressure should take their medication all year
By reducing NNMT, the bodys ability to burn fat doesnt slow down and fat cells dont continue growing
Each medication functions along the GLP-1 pathway, curbing hunger and promoting fullness
Your preferences: Some individuals prefer the convenience of taking a daily pill, while others may find B12 shots less invasive
Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes